Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Gs7l1rur5i
2. (r)-a-1443
3. A-663
4. 1122022-03-0
5. Benzamide, 4-((5r)-5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl)-2-methyl-n-(2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)-
6. Unii-gs7l1rur5i
7. Schembl8515337
8. Dtxsid301101022
9. 4-[(5r)-5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]benzamide
| Molecular Weight | 556.3 g/mol |
|---|---|
| Molecular Formula | C22H17Cl2F6N3O3 |
| XLogP3 | 5.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 6 |
| Exact Mass | 555.0551158 g/mol |
| Monoisotopic Mass | 555.0551158 g/mol |
| Topological Polar Surface Area | 79.8 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 846 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
VMF Number : 6509
Submission : 2023-02-24
Status : Active
Type : II





FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
NDC Package Code : 69011-0008
Start Marketing Date : 2025-04-24
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 42513-0019
Start Marketing Date : 2023-01-05
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 13612-0023
Start Marketing Date : 2021-05-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]VMF Number : 6509
Submission : 2023-02-24
Status : Active
Type : II
VMF Number : 6422
Submission : 2021-04-20
Status : Active
Type : II

VMF Number : 6480
Submission : 2022-07-25
Status : Active
Type : II

VMF Number : 6284
Submission : 2018-12-20
Status : Active
Type : II

VMF Number : 6012
Submission : 2012-03-26
Status : Active
Type : II

VMF Number : 6285
Submission : 2018-12-20
Status : Active
Type : II

VMF Number : 6439
Submission : 2021-08-10
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CAS Number : 55860-35-0
End Use API : Fluralaner
About The Company : Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in API and advanced intermediate R&D and manufacturing, delivering comprehensive CDMO/CRO/OEM se...
2-AMino-N-(2,2,2- trifluoroethyl)acetaMide hydroch...
CAS Number : 1171331-39-7
End Use API : Fluralaner
About The Company : Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in API and advanced intermediate R&D and manufacturing, delivering comprehensive CDMO/CRO/OEM se...
3',5'-DICHLORO-2,2,2- TRIFLUOROACETOPHENONE
CAS Number : 130336-16-2
End Use API : Fluralaner
About The Company : Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in API and advanced intermediate R&D and manufacturing, delivering comprehensive CDMO/CRO/OEM se...
CAS Number : 55860-35-0
End Use API : Fluralaner
About The Company : Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square mete...
1-(3,5-Dichlorophenyl)-2,2,2-trifluoroethan-1-one
CAS Number : 130336-16-2
End Use API : Fluralaner
About The Company : Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square mete...
2-Amino-N-(2,2,2-Trifluoroethyl) acetamide HCl
CAS Number : 1171331-39-7
End Use API : Fluralaner
About The Company : Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square mete...
CAS Number : 55860-35-0
End Use API : Fluralaner
About The Company : Founded in 2006, ChemExpress provides CRO and CDMO services to pharmaceutical and biotech companies. The company supports small molecules, biologics, and new mo...
CAS Number : 55860-35-0
End Use API : Fluralaner
About The Company : Aventus Labs is a forward-thinking pharmaceutical company committed to developing and delivering high-quality, effective healthcare solutions. With a focus on r...

CAS Number : 55860-35-0
End Use API : Fluralaner
About The Company : BDBiochem Technology is an innovative life science partner specializing in high-quality custom chemical and biochemical solutions for the pharmaceutical, biotec...

4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-...
CAS Number : 864725-62-2
End Use API : Fluralaner
About The Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our cor...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Chewable Tablet
Dosage Strength : 112.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Chewable Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Chewable Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Chewable Tablet
Dosage Strength : 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Chewable Tablet
Dosage Strength : 1400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Spot-on Solution
Dosage Strength : 280MG/1ML; 14 MG/1ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : China
Brand Name : Fluralaner
Dosage Form : Spot-On Solution
Dosage Strength : 280MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Bravecto
Dosage Form : Powder For Injection
Dosage Strength : 150mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Bravecto
Dosage Form : Solution
Dosage Strength : 1000mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Bravecto
Dosage Form : Solution
Dosage Strength : 112.5mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
13
PharmaCompass offers a list of Fluralaner API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Fluralaner manufacturer or Fluralaner supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fluralaner manufacturer or Fluralaner supplier.
A Fluralaner manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fluralaner, including repackagers and relabelers. The FDA regulates Fluralaner manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fluralaner API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fluralaner manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Fluralaner supplier is an individual or a company that provides Fluralaner active pharmaceutical ingredient (API) or Fluralaner finished formulations upon request. The Fluralaner suppliers may include Fluralaner API manufacturers, exporters, distributors and traders.
click here to find a list of Fluralaner suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fluralaner as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fluralaner API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fluralaner as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fluralaner and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fluralaner NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fluralaner suppliers with NDC on PharmaCompass.
Fluralaner Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fluralaner GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Fluralaner GMP manufacturer or Fluralaner GMP API supplier for your needs.
A Fluralaner CoA (Certificate of Analysis) is a formal document that attests to Fluralaner's compliance with Fluralaner specifications and serves as a tool for batch-level quality control.
Fluralaner CoA mostly includes findings from lab analyses of a specific batch. For each Fluralaner CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fluralaner may be tested according to a variety of international standards, such as European Pharmacopoeia (Fluralaner EP), Fluralaner JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fluralaner USP).